tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GYRE Stock Latest News

new option listings on April 9th
The Flynew option listings on April 9th
2d ago
LIF
MBX
Gyre Therapeutics announces NMPA approval for trial on pirfenidone
PremiumThe Fly
Gyre Therapeutics announces NMPA approval for trial on pirfenidone
11d ago
GYRE
Gyre Therapeutics announces publication of protocol for Phase 3 trial on F351
PremiumThe Fly
Gyre Therapeutics announces publication of protocol for Phase 3 trial on F351
15d ago
GYRE
Gyre Therapeutics Reports Strong Turnaround in 2024 Earnings
PremiumCompany Announcements
Gyre Therapeutics Reports Strong Turnaround in 2024 Earnings
22d ago
GYRE
Impact of New U.S. Regulations on Gyre Therapeutics: Potential Delisting Risks and Investor Concerns
PremiumCompany Announcements
Impact of New U.S. Regulations on Gyre Therapeutics: Potential Delisting Risks and Investor Concerns
24d ago
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe FlyCatalyst Biosciences Inc trading resumes
24d ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
Premium
The Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
24d ago
GYRE
Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year
Premium
The Fly
Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year
25d ago
GYRE
Gyre Therapeutics initiated with an Outperform at Noble Capital
PremiumThe Fly
Gyre Therapeutics initiated with an Outperform at Noble Capital
1M ago
GYRE
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects
PremiumCompany Announcements
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects
2M ago
8K
GYRE
Five new option listings and option delistings on January 21st
PremiumThe Fly
Five new option listings and option delistings on January 21st
3M ago
SQ
ADN
Leadership Changes at Gyre Therapeutics Amid Strategic Shift
PremiumCompany Announcements
Leadership Changes at Gyre Therapeutics Amid Strategic Shift
3M ago
8K
GYRE
Gyre Therapeutics appoints Ping Zhang to board of directors
PremiumThe FlyGyre Therapeutics appoints Ping Zhang to board of directors
3M ago
GYRE
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
Premium
Company Announcements
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
5M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
Premium
The Fly
Gyre Therapeutics files $150M mixed securities shelf
5M ago
GYRE
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
PremiumThe Fly
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
6M ago
GYRE
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
PremiumCompany Announcements
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
8M ago
8K
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
8M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
8M ago
GYRE
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
PremiumCompany AnnouncementsGyre Therapeutics Seeks Compliance Amid Board Reshuffle
9M ago
8K
GYRE
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
Premium
The Fly
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
9M ago
GYRE
Gyre announces publication in Journal of Gastroenterology and Hepatology
Premium
The Fly
Gyre announces publication in Journal of Gastroenterology and Hepatology
10M ago
GYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >